Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other health care products. The company manufactures products in various forms, including capsules, tablets, chewable wafers and powders.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $178.5M | $171.0M | $154.0M | $113.8M | $129.9M |
| Gross profit | $30.4M | $30.5M | $18.2M | $6.9M | $9.3M |
| Operating income | $13.7M | $13.7M | $4.7M | -$8.5M | -$8.7M |
| Net income | $10.8M | $10.7M | $2.5M | -$7.2M | -$13.6M |
| Diluted EPS | $1.69 | $1.74 | $0.43 | -$1.23 | -$2.28 |
| Operating cash flow | $20.8M | $11.9M | $7.0M | -$1.5M | $5.9M |
| Free cash flow | $15.7M | -$14.6M | -$6.5M | -$4.5M | $2.3M |
| Gross margin | 17.1% | 17.8% | 11.8% | 6.0% | 7.2% |
| Operating margin | 7.7% | 8.0% | 3.1% | -7.5% | -6.7% |
| Net margin | 6.0% | 6.3% | 1.6% | -6.3% | -10.5% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29.5M | $33.1M | $34.1M | $28.8M | $33.9M | $37.7M | $34.8M | $35.5M |
| Gross profit | $1.4M | $2.3M | $1.7M | $1.8M | $3.5M | $4.4M | $2.5M | $383,000.00 |
| Operating income | — | -$1.8M | -$2.8M | -$2.1M | -$1.9M | $284,000.00 | -$1.8M | -$4.0M |
| Net income | -$1.9M | -$2.0M | -$2.2M | -$2.2M | -$7.2M | -$291,000.00 | -$2.6M | -$4.3M |
| Diluted EPS | -$0.32 | -$0.33 | -$0.37 | -$0.37 | -$1.21 | -$0.05 | -$0.42 | -$0.72 |
| Operating cash flow | -$2.7M | -$3.4M | $37,000.00 | $6.0M | $3.3M | -$4.0M | -$6.3M | $2.5M |
| Free cash flow | -$3.8M | -$3.7M | -$1.0M | $5.2M | $1.9M | -$5.1M | -$7.3M | $1.4M |
| Gross margin | 4.8% | 6.8% | 4.9% | 6.3% | 10.4% | 11.7% | 7.2% | 1.1% |
| Operating margin | — | -5.5% | -8.2% | -7.3% | -5.7% | 0.8% | -5.3% | -11.3% |
| Net margin | -6.4% | -6.0% | -6.4% | -7.6% | -21.3% | -0.8% | -7.3% | -12.1% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-06 | WOLF KENNETH· President, COO, & Sec. | Tax withholding | 5,151 | $2.73 | $14,062.23 | filing |
| 2026-03-06 | Fortin Michael E· Chief Financial Officer | Tax withholding | 4,308 | $2.73 | $11,760.84 | filing |
| 2026-03-06 | LEDOUX MARK A· CEO/Chairman | Tax withholding | 3,484 | $2.73 | $9,511.32 | filing |
| 2026-03-06 | LEDOUX MARK A· CEO/Chairman | Buy | 532 | $2.80 | $1,489.60 | filing |
| 2026-03-06 | Matherly Laura Kay | Award | 8,000 | $0.00 | $0.00 | filing |
| 2026-03-06 | Ramanathan Guru | Award | 8,000 | $0.00 | $0.00 | filing |
| 2026-03-06 | Dunn Alan G | Award | 8,000 | $0.00 | $0.00 | filing |
| 2026-03-06 | WOLF KENNETH· President, COO, & Sec. | Award | 15,000 | $0.00 | $0.00 | filing |
| 2026-03-06 | Fortin Michael E· Chief Financial Officer | Award | 12,000 | $0.00 | $0.00 | filing |
| 2026-03-06 | LEDOUX MARK A· CEO/Chairman | Award | 20,000 | $0.00 | $0.00 | filing |
| 2026-03-05 | LEDOUX MARK A· CEO/Chairman | Buy | 218 | $2.75 | $599.50 | filing |
| 2026-03-04 | LEDOUX MARK A· CEO/Chairman | Buy | 500 | $2.77 | $1,385.00 | filing |
| 2026-03-02 | LEDOUX MARK A· CEO/Chairman | Buy | 500 | $2.79 | $1,395.00 | filing |
| 2026-02-27 | LEDOUX MARK A· CEO/Chairman | Buy | 500 | $2.85 | $1,425.00 | filing |
| 2026-02-27 | LEDOUX MARK A· CEO/Chairman | Buy | 250 | $2.80 | $700.00 | filing |
| 2026-02-26 | LEDOUX MARK A· CEO/Chairman | Buy | 500 | $2.85 | $1,423.00 | filing |
| 2026-02-25 | LEDOUX MARK A· CEO/Chairman | Buy | 500 | $2.81 | $1,405.00 | filing |
| 2026-02-24 | LEDOUX MARK A· CEO/Chairman | Buy | 1,000 | $2.71 | $2,710.00 | filing |
| 2026-02-23 | LEDOUX MARK A· CEO/Chairman | Buy | 750 | $2.70 | $2,025.00 | filing |
| 2026-02-20 | LEDOUX MARK A· CEO/Chairman | Buy | 250 | $2.66 | $663.75 | filing |
| 2026-02-19 | LEDOUX MARK A· CEO/Chairman | Buy | 1,500 | $2.56 | $3,832.50 | filing |
| 2026-02-18 | LEDOUX MARK A· CEO/Chairman | Buy | 500 | $2.56 | $1,281.50 | filing |
| 2026-02-17 | LEDOUX MARK A· CEO/Chairman | Buy | 2,500 | $2.60 | $6,490.00 | filing |
| 2025-12-23 | LEDOUX MARK A· CEO/Chairman | Gift | 10,000 | — | — | filing |
Latest 24 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.